The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell (Q37839809)

24 August 2017

1 reference

title

The cystic fibrosis neutrophil: a specialized yet potentially defective cell (English)

1 reference

24 August 2017

The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell (English)

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

24 November 2024

main subject

cystic fibrosis

0 references

neutrophil activation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21311988

24 November 2024

author name string

Elaine Hayes

1

1 reference

24 August 2017

Kerstin Pohl

2

1 reference

24 August 2017

Noel G. McElvaney

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21311988

24 November 2024

Emer P. Reeves

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21311988

24 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21311988

24 November 2024

publication date

11 February 2011

1 reference

full work available at URL

24 August 2017

http://link.springer.com/content/pdf/10.1007/s00005-011-0113-6.pdf

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

http://link.springer.com/article/10.1007/s00005-011-0113-6/fulltext.html

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

http://link.springer.com/content/pdf/10.1007/s00005-011-0113-6

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Archivum Immunologiae et Therapiae Experimentalis

24 November 2024

published in

1 reference

24 August 2017

volume

59

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

97-112

1 reference

Neutrophils in cystic fibrosis display a distinct gene expression pattern

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Erythromycin shortens neutrophil survival by accelerating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Lower airway inflammation in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Comparative aspects of oxidative metabolism of neutrophils from human blood and guinea pig peritonea: Magnitude of the respiratory burst, dependence upon stimulating agents, and localization of the oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Neutrophil granules: a library of innate immunity proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Effect of cystic fibrosis exacerbations on neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Normal neutrophil and monocyte chemotaxis in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Cationic polypeptides are required for antibacterial activity of human airway fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Desensitisation of neutrophil responses by systemic interleukin 8 in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

The paradox of matrix metalloproteinases in infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Inflammatory resolution: new opportunities for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Neutrophil priming: the cellular signals that say 'amber' but not 'green'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Glutathione levels and BAX activation during apoptosis due to oxidative stress in cells expressing wild-type and mutant cystic fibrosis transmembrane conductance regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Exhaled breath condensate MMP-9 levels in children with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Effect of high-dose ibuprofen in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Getting to the site of inflammation: the leukocyte adhesion cascade updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Abnormalities in the pulmonary innate immune system in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Reduced iC3b-mediated phagocytotic capacity of pulmonary neutrophils in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Ultrastructural cytochemistry of complex carbohydrates in leukocyte granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Gene therapy for airway diseases: continued progress toward identifying and overcoming barriers to efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Predictive Value of Oropharyngeal Cultures for Identifying Lower Airway Bacteria in Cystic Fibrosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Killing activity of neutrophils is mediated through activation of proteases by K flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Reactive oxygen species limit neutrophil life span by activating death receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Novel cytochrome b system in phagocytic vacuoles of human granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Modern management of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Macrolides and airway inflammation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

The continuing saga of complement receptor type 3 (CR3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Activity of abundant antimicrobials of the human airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Inhibitory capacity of different steroids on neutrophil migration across a bilayer of endothelial and bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Neutrophil cell death, activation and bacterial infection in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Neutrophils: molecules, functions and pathophysiological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Transport governs flow-enhanced cell tethering through L-selectin at threshold shear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Role of reactive oxygen species in neutrophil apoptosis following ingestion of heat-killed Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Cystic fibrosis: genotypic and phenotypic variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Interleukin-8 Concentrations Are Elevated in Bronchoalveolar Lavage, Sputum, and Sera of Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

CYSTIC FIBROSIS SPUTUM STIMULATES CD18-INDEPENDENT NEUTROPHIL MIGRATION ACROSS ENDOTHELIAL CELLS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis

21 January 2018

11

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Protease-antiprotease imbalance in the lungs of children with cystic fibrosis

24 November 2024

18

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis.

24 November 2024

22

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition

24 November 2024

25

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Granulocyte elastase-mediated proteolysis of alpha 1-antitrypsin in cystic fibrosis bronchopulmonary secretions

24 November 2024

28

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Altered intracellular pH regulation in neutrophils from patients with cystic fibrosis

24 November 2024

32

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis

24 November 2024

36

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

In vitro activation of pro-cathepsin B by three serine proteinases: leucocyte elastase, cathepsin G, and the urokinase-type plasminogen activator

24 November 2024

39

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Gene therapy for cystic fibrosis

24 November 2024

40

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Circulating Adhesion Molecules in Cystic Fibrosis

24 November 2024

42

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

CD11/CD18-dependent and -independent neutrophil emigration in the lungs: how do neutrophils know which route to take?

24 November 2024

47

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

24 November 2024

49

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury

24 November 2024

52

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Involvement of two types of TNF receptor in TNF-alpha induced neutrophil apoptosis

24 November 2024

59

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages

24 November 2024

71

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Burkholderia cepacia Produces a Hemolysin That Is Capable of Inducing Apoptosis and Degranulation of Mammalian Phagocytes

24 November 2024

74

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease

24 November 2024

75

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction

24 November 2024

77

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Metabolic Basis of Phagocytic Activity

24 November 2024

82

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Respiratory burst during phagocytosis: an overview

24 November 2024

83

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis

24 November 2024

87

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension

24 November 2024

90

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis

24 November 2024

92

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema

24 November 2024

95

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Aerosol α1 -antitrypsin treatment for cystic fibrosis

24 November 2024

100

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Polymorphonuclear leukocyte adherence to nylon: effect of oral corticosteroids

24 November 2024

102

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Prolonged survival of neutrophils from patients with F508 CFTR mutations

24 November 2024

103

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Inhibition of neutrophil migration at the site of infection increases remote organ neutrophil sequestration and injury

24 November 2024

106

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Remodeling of the plasma membrane after stimulation of neutrophils with f-Met-Leu-Phe and dihydrocytochalasin B: identification of membrane subdomains containing NADPH oxidase activity

24 November 2024

112

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis

24 November 2024

115

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G

24 November 2024

120

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Isolation and characterization of glycosaminoglycans from human leukocytes and platelets

24 November 2024

121

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis

24 November 2024

126

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10

24 November 2024

128

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Neutrophil chemotaxis in acutely infected and clinically stable cystic fibrosis patients

24 November 2024

149

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Oxidative changes of bronchoalveolar proteins in cystic fibrosis

24 November 2024

157

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8

24 November 2024

161

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Antileukoprotease: An Endogenous Protein in the Innate Mucosal Defense against Fungi

24 November 2024

169

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Myeloperoxidase and protein oxidation in cystic fibrosis

24 November 2024

176

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium

24 November 2024

179

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections

24 November 2024

183

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis

24 November 2024

187

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection

24 November 2024

191

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa

24 November 2024

192

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation

24 November 2024

193

1 reference

https://api.crossref.org/works/10.1007/S00005-011-0113-6

24 November 2024

Identifiers

1 reference

24 August 2017

1 reference